James C. Yang-Hsin
7 Chung Shan South Road
TPQ 10002, Taiwan
TPQ 10002, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Savolitinib Plus Osimertinib in Epidermal Growth Factor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase II trial.
Journal: Clinical lung cancer
Published: August 19, 2025
PD-L1 regulates c-MET phosphorylation and contributes to MET-dependent resistance to osimertinib in EGFR-mutant NSCLC.
Journal: Journal of biomedical science
Published: July 30, 2025
Sunvozertinib monotherapy in EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancer with EGFR mutations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: August 13, 2024
Pembrolizumab With or Without Lenvatinib for First-Line Metastatic NSCLC With Programmed Cell Death-Ligand 1 Tumor Proportion Score of at least 1% (LEAP-007): A Randomized, Double-Blind, Phase 3 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 05, 2023
Efficacy and safety of tepotinib in Asian patients with advanced NSCLC with MET exon 14 skipping enrolled in VISION.
Journal: British journal of cancer
Published: October 02, 2023
Evaluation of combination treatment with DS-1205c, an AXL kinase inhibitor, and osimertinib in metastatic or unresectable EGFR-mutant non-small cell lung cancer: results from a multicenter, open-label phase 1 study.
Journal: Investigational new drugs
Published: January 30, 2023
Real-world insights into patients with advanced NSCLC and MET alterations.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: March 22, 2021
CD73 Is Regulated by the EGFR-ERK Signaling Pathway in Non-small Cell Lung Cancer.
Journal: Anticancer research
Published: January 12, 2021
Clinical utility of plasma EGFR mutation detection with quantitative PCR in advanced lung cancer: A meta-analysis.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: December 20, 2020
Esomeprazole-induced Stevens-Johnson syndrome in a patient who underwent nivolumab therapy for advanced lung adenocarcinoma.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: July 28, 2020
Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: May 18, 2020
Checkpoint Inhibitor Combined With Tyrosine Kinase Inhibitor-the End or Beginning?
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: December 03, 2019
Last Updated: 09/26/2026